EDDC (Experimental Drug Development Centre), A*STAR Research Entities
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study of EBC-129 in Advanced Solid Tumours | Advanced Solid Tumours | Recruiting | Phase 1 | 2026-02-05 | NCT05701527 | |
| ETC-159 In Combination With Pembrolizumab In Advanced MSS/pMMR Ovarian Cancers | With MSS/pMMR Advanced, Platinum-resistant Ovarian Cancer | Recruiting | Phase 1 | 2025-07-25 | NCT06513624 | |
| A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours | Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, endometrium neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, uterine disorder | Active, not recruiting | Phase 1 | 2024-10-08 | NCT02521844 |